These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 33093691

  • 1. Masked Hypertension: Lessons for the Future.
    Penmatsa KR, Biyani M, Gupta A.
    Ulster Med J; 2020 Sep; 89(2):77-82. PubMed ID: 33093691
    [Abstract] [Full Text] [Related]

  • 2. An Update on Masked Hypertension.
    Anstey DE, Pugliese D, Abdalla M, Bello NA, Givens R, Shimbo D.
    Curr Hypertens Rep; 2017 Oct 25; 19(12):94. PubMed ID: 29071520
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. When Office Blood Pressure Is Not Enough: The Case of Masked Hypertension.
    Cuspidi C, Sala C, Tadic M, Grassi G.
    Am J Hypertens; 2019 Feb 12; 32(3):225-233. PubMed ID: 30508171
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Diagnosis and management of patients with white-coat and masked hypertension.
    Mancia G, Bombelli M, Seravalle G, Grassi G.
    Nat Rev Cardiol; 2011 Aug 09; 8(12):686-93. PubMed ID: 21826071
    [Abstract] [Full Text] [Related]

  • 7. Current approach to masked hypertension: From diagnosis to clinical management.
    Dolan E, James K.
    Clin Exp Pharmacol Physiol; 2017 Dec 09; 44(12):1272-1278. PubMed ID: 24283851
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Epidemiological Impact and Clinical Consequences of Masked Hypertension: A Narrative Review.
    Cesario V, Presta V, Figliuzzi I, Citoni B, Battistoni A, Miceli F, Volpe M, Tocci G.
    High Blood Press Cardiovasc Prev; 2020 Jun 09; 27(3):195-201. PubMed ID: 32361899
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Target Organ Complications and Cardiovascular Events Associated With Masked Hypertension and White-Coat Hypertension: Analysis From the Dallas Heart Study.
    Tientcheu D, Ayers C, Das SR, McGuire DK, de Lemos JA, Khera A, Kaplan N, Victor R, Vongpatanasin W.
    J Am Coll Cardiol; 2015 Nov 17; 66(20):2159-2169. PubMed ID: 26564592
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Recognition and management of masked hypertension: a review and novel approach.
    Yano Y, Bakris GL.
    J Am Soc Hypertens; 2013 Nov 17; 7(3):244-52. PubMed ID: 23523411
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Masked Hypertension: Whom and How to Screen?
    Anstey DE, Moise N, Kronish I, Abdalla M.
    Curr Hypertens Rep; 2019 Apr 04; 21(4):26. PubMed ID: 30949843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.